A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the ...
PathChat, a new AI model for pathology made by Modella AI, received breakthrough status in January. The device can digest ...
This was the stock's second consecutive day of gains.